Novartis (United States)

New York (United States us)
Molecular Biology
Clinical endpoint Tolerability Treatment Sacubitril Discontinuation Sacubitril, Valsartan Everolimus Indacaterol Breast Cancer T Cell Therapy
Watch Introduction

Bibliometric indicators

Evolution over the last years of activity

Showing the period - Sept. 2024

10,349
Activity
3%

Total documents

2.78
Impact
3%

Normalized Impact

2,462
Excellence
3%

Highly Cited Papers (Top 10%)

56.5
Leadership
3%

Leadership (%)

59.5
Mobility & Collaboration
3%

International Collaboration (%)

493
Excellence
3%

Outstanding papers (Top 1%)

13.5
Leadership
3%

Women Leading (%)

7.4
Leadership
3%

Women Leading International (%)

52.0
Open Access
3%

Open Access (%)

Main Research Fields (top 9 by publications)

Indicators:

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Human Resources

Historical perspective

From to Sept. 2024

Current resources

Quick filters

Career Stage
Occasional Junior Researcher Senior Leading
Performance
Standard Good Excellent Outstanding
Gender
Male Female
Reset
0

Personnel

0.0

Papers / Personnel

0

Leading women (%)

0
0

Gender (%)

0

Papers / Permanent researchers

0

Papers / Leading researchers

Career stage

Performance

Years of Activity

ONE Index (distribution)

ONE Index by Main Research Fields

ONE Index vs. Years of Activity

Main authors

ID Name Gender Discipline Career Stage ONE Index Years Activity NDocs RCI HCP Leader Collab.
1 Jeffrey B. Ulmer Immunology Leading researcher 850 39 199 2.91 52 52.8% 22.1%
2 Victor Chengwei Shi Cardiology and Cardiovascular Medicine Senior researcher 818 25 166 9.63 82 10.2% 68.1%
3 Clifford A. Brass Hepatology, Epidemiology Leading researcher 807 44 179 4.23 48 22.4% 43.6%
4 Ma ́en Obeidat Obstetrics and Gynecology Junior researcher 800 3 7 101.75 6 0.0% 100.0%
5 Foley, James male Endocrinology, Diabetes and Metabolism Leading researcher 793 98 173 2.70 55 50.9% 33.5%
6 Schirle, Markus male Molecular Biology Senior researcher 789 27 126 5.98 65 15.1% 37.3%
7 Park, Yujin male Researcher 789 13 102 1.32 15 39.2% 9.8%
8 Cong, Feng male Molecular Biology Senior researcher 789 26 85 4.03 35 44.7% 32.9%
9 Barnett, Susan female Virology, Immunology Leading researcher 787 43 178 2.11 34 23.6% 42.7%
10 Martin P. Lefkowitz Cardiology and Cardiovascular Medicine Leading researcher 787 61 224 7.80 114 13.0% 65.2%
11 Family Name Deactivated, Given Names Deactivated male Pulmonary and Respiratory Medicine, Oncology Senior researcher 784 16 80 3.99 26 13.8% 53.8%
12 Peter M. Dull Epidemiology Leading researcher 779 35 113 3.84 37 40.7% 50.4%
13 Donald D. Banerji Pulmonary and Respiratory Medicine Leading researcher 773 74 229 1.45 27 72.9% 67.7%
14 Peter W. Atadja Molecular Biology Leading researcher 770 31 207 2.47 69 15.5% 30.0%
15 Altman, Pablo male Pulmonary and Respiratory Medicine Researcher 768 13 43 1.40 10 74.4% 67.4%
16 Ciferri, Claudio male Molecular Biology Senior researcher 768 20 70 3.96 31 32.9% 27.1%
17 Jenkins, Jeremy male Molecular Biology Senior researcher 767 26 128 2.96 34 29.7% 34.4%
18 Urban, Laszlo male Leading researcher 751 56 419 6.16 79 39.4% 43.6%
19 Mesenbrink, Peter male Orthopedics and Sports Medicine Senior researcher 748 26 92 4.02 29 14.1% 63.0%
20 Dovala, Dustin male Molecular Biology Researcher 745 11 45 4.56 21 8.9% 37.8%
21 Tallarico, John male Molecular Biology Leading researcher 745 30 114 5.08 61 14.0% 39.5%
22 Fogel, Robert male Pulmonary and Respiratory Medicine Leading researcher 741 54 168 2.03 42 25.0% 62.5%
23 Argikar, Upendra female Molecular Biology, Pharmacology Senior researcher 739 20 80 1.82 12 53.8% 31.3%
24 Pricop, Luminita female Rheumatology Leading researcher 734 52 161 2.18 28 23.0% 57.8%
25 Scosyrev, Emil male Surgery Senior researcher 731 19 60 3.32 16 78.3% 16.7%
850
One Index
 Jeffrey B. Ulmer PhD 199 docs (1986 - 2024)  
Antigen Presentation , Vaccines , CTL* , HIV , Vaccine Adjuvants
818
One Index
 Victor Chengwei Shi PhD 166 docs (2000 - 2023)  
Sacubitril , Sacubitril, Valsartan , Treatment , Clinical endpoint , Hypertension
807
One Index
 Clifford A. Brass PhD 179 docs (1981 - 2024)  
Boceprevir , Treatment , Hepatitis C , Pegylated interferon , Steatohepatitis
800
One Index
 Ma ́en Obeidat 7 docs (2022 - 2023)  
Genome-wide association study , Genetic association , Pregnancy Complications , Genetic predisposition , Stroke (engine)
793
One Index
 Foley, James PhD   0000-0001-6857-1158 173 docs (1927 - 2022)  
Vildagliptin , Type 2 Diabetes , Diabetes , Insulin Therapy , Insulin Signaling
789
One Index
 Schirle, Markus PhD   0000-0003-4933-2623 126 docs (1998 - 2024)  
Protein Degradation , Epigenetic Readers , Druggability , Proteomics , Proteome
789
One Index
 Park, Yujin PhD   0000-0002-7936-9307 102 docs (2012 - 2024)  
Ankylosing Spondylitis , Spondyloarthritis , Treatment Recommendations , Discontinuation , Dactylitis
789
One Index
 Cong, Feng PhD   0000-0002-0666-8656 85 docs (1999 - 2024)  
Wnt Signaling , LRP6 , Realgar , LRP5 , ABL
787
One Index
 Barnett, Susan PhD   0000-0003-4586-1018 178 docs (1982 - 2024)  
HIV , Immune Responses , Antibodies , Immune Activation , Vaccines
787
One Index
 Martin P. Lefkowitz PhD 224 docs (1964 - 2024)  
Sacubitril , Sacubitril, Valsartan , Clinical endpoint , Treatment , Hypertension
784
One Index
 Family Name Deactivated, Given Names Deactivated PhD   0000-0001-6140-7304 80 docs (2009 - 2024)  
Genome-wide association study , Therapeutic Guidelines , Survival Analysis , Genetic association , Fetal Hemoglobin
779
One Index
 Peter M. Dull PhD 113 docs (1990 - 2024)  
Meningococcal vaccine , Reactogenicity , Vaccination , Booster dose , Pneumococcal Conjugate Vaccine
773
One Index
 Donald D. Banerji PhD 229 docs (1951 - 2020)  
Indacaterol , COPD , Salmeterol , Lama , Fluticasone
770
One Index
 Peter W. Atadja PhD 207 docs (1994 - 2023)  
Panobinostat , HDAC Inhibitors , Histone deacetylase inhibitor , Histone Deacetylases , PRC2
768
One Index
 Altman, Pablo PhD   0000-0002-4799-903X 43 docs (2012 - 2024)  
COPD , Indacaterol , pulmonary disease , Dry Powder Inhalers , Lama
768
One Index
 Ciferri, Claudio PhD   0000-0002-0804-2411 70 docs (2005 - 2023)  
PRC2 , Pentamer , Voltage-Gated Channels , Transcytosis , Polymeric immunoglobulin receptor
767
One Index
 Jenkins, Jeremy PhD   0000-0001-9795-0771 128 docs (1999 - 2024)  
Drug Target Identification , Chemical space , Cheminformatics , High-throughput screening , Profiling (computer programming)
751
One Index
 Urban, Laszlo PhD   0000-0002-1275-0293 419 docs (1969 - 2024)  
Pain Modulation , Electron–positron annihilation , Capsaicin , Drug Target Identification , Dorsal root ganglion
748
One Index
 Mesenbrink, Peter PhD   0000-0002-5624-6726 92 docs (1999 - 2024)  
Zoledronic Acid , Bone Mineral Density , Bone remodeling , Zoledronic acid , Osteoporotic Fractures
745
One Index
 Dovala, Dustin PhD   0000-0002-2278-5027 45 docs (2014 - 2024)  
Protein Degradation , Coronavirus , Deubiquitinating enzyme , Septin , Corona Virus
745
One Index
 Tallarico, John PhD   0000-0002-8040-8422 114 docs (1995 - 2024)  
Protein Degradation , Epigenetic Readers , Druggability , Cyclobutadiene , Natural product
741
One Index
 Fogel, Robert PhD   0000-0002-1441-0962 168 docs (1971 - 2022)  
Indacaterol , COPD , Salmeterol , Fluticasone , Lama
739
One Index
 Argikar, Upendra PhD   0000-0002-0939-0813 80 docs (2005 - 2024)  
Drug Metabolism , Enzyme Activities , Biotransformation , Pharmacokinetics , Complement (music)
734
One Index
 Pricop, Luminita PhD 161 docs (1973 - 2024)  
Psoriatic Arthritis , Treatment Recommendations , Fc? Receptors , Clinical endpoint , Dactylitis
731
One Index
 Scosyrev, Emil PhD   0000-0003-4601-1170 60 docs (2006 - 2024)  
Bladder Cancer , Metastatic Bladder Cancer , Metastatic Prostate Cancer , Prostate Cancer , Neoadjuvant Therapy